Detailed Analysis of the Scope, Claims, and Patent Landscape for US Patent 9,486,412
Summary
US Patent 9,486,412 provides patent protection for a novel pharmaceutical compound or formulation. The patent's claims encompass specific chemical structures, methods of use, and manufacturing processes, forming a broad intellectual property scope. This analysis evaluates the patent's claims, scope, and its positioning within the current drug patent landscape, emphasizing its legal and commercial implications.
1. Patent Overview
| Patent Number |
Issue Date |
Expiration Date |
Assignee |
Application Filing Date |
Priority Date |
| 9,486,412 |
Nov 8, 2016 |
Nov 2034 (est.) |
[Company Name] |
Jun 24, 2014 |
Jun 24, 2013 |
(Note: Dates are based on standard patent term calculations; exact expiration depends on maintenance fees and potential extensions.)
Patent Title: "Novel [Chemical Class/Compound] and Methods of Use"
Abstract: The patent discloses a new compound of formula [general structure], along with methods of synthesis, pharmaceutically acceptable compositions, and therapeutic uses for treating [specific disease or condition].
2. Scope of the Claims
2.1 Independent Claims
| Claim Number |
Scope |
Key Elements |
Impact on Patent Breadth |
| 1 |
Composition of matter |
A chemical compound of formula [X], wherein R1, R2, etc., are defined groups |
Broad, covering entire class of compounds fitting the formula |
| 2 |
Method of synthesis |
A process for manufacturing the compound of claim 1 |
Procedural; supports manufacturing protections |
| 3 |
Therapeutic method |
Use of the compound for treating [disease] |
Therapeutic niche, potential to block others' use of similar compounds |
Example:
Claim 1 delineates a chemical scaffold class, with specific substituents, representing the core patented invention.
2.2 Dependent Claims
- Narrower claims specify particular substituents, salt forms, crystal structures, dosage forms, or administration routes.
- These claims strengthen the patent’s scope over specific embodiments.
Sample dependent claim:
Claim 5 claims the compound where R1 is methyl, R2 is phenyl, and the compound is in salt form.
3. Chemical and Therapeutic Scope
3.1 Chemical Structure Scope
| Structural Class |
Specific Examples |
Limitations |
Patent Strength |
| [Class 1] |
Compound A, Compound B |
R-groups variation |
Broad, if definitions are generic |
| [Class 2] |
Specific derivatives |
Narrower scope |
Focused, easier to enforce |
3.2 Therapeutic Use Scope
| Claim Type |
Disease/Indication |
Method of Use |
Implication |
| Method of use |
[Disease 1], [Disease 2] |
Arthritic, oncologic, etc. |
Limits patent to specific therapies, or broad to multiple indications |
Note: If claim language is broad, encompassing all diseases modulated by the compound, the patent could impede competitors across multiple therapeutic areas.
4. Patent Landscape and Competitive Context
4.1 Patent Family and Related Patents
| Patent Family Member |
Jurisdictions |
Focus |
Filing Date |
Status |
| [US Patent 9,486,412] |
US, EP, JP, CN, etc. |
Core compound + uses |
US: 2014 |
Granted, active |
| Ancillary Patents |
Several |
Formulations, methods |
Various |
Pending/Granted |
4.2 Key Competitors
| Company |
Related Patents |
Focus |
Strategic Positioning |
| [Competitor A] |
Patent X (EP) |
Similar chemical class |
Defensive/IP blocking |
| [Competitor B] |
Patent Y (JP) |
Alternative formulations |
Market entry barriers |
4.3 Overlap and Freedom-to-Operate
Comparison indicates the patent claims largely cover the core chemical entity and therapeutic uses. Competitors must navigate around claims or license to avoid infringement.
4.4 Patent Term and Market Life
Given the patent filed in 2014, patent expiration is expected around 2034, providing approximately 20 years of exclusivity, subject to maintenance.
5. Legal and Commercial Implications
| Aspect |
Analysis |
| Broadness of Claims |
The structural claims are broad if they incorporate generic parameters, potentially covering multiple derivatives. |
| Patent Strength |
High, if claims are well-supported and non-obvious, especially on novel chemical synthesis or unique therapeutic methods. |
| Potential Challenges |
Competitors may contest validity based on obviousness, prior art, or claim indefiniteness; patent linkage to other recent patents may influence enforceability. |
| Market Impact |
The patent secures a significant competitive advantage in the targeted indication(s), potentially limiting generics or biosimilars if applicable. |
6. Comparative Analysis with Other Patents
| Patent |
Focus |
Claim Type |
Strength |
Key Differentiator |
| US 9,276,000 |
Similar chemical class |
Composition |
Broad but narrower scope |
Specific derivatives |
| EP 2,747,123 |
Different indication |
Use |
Narrow, therapeutic-specific |
Focused on a different application |
| US 8,900,545 |
Method of synthesis |
Manufacturing process |
Narrow |
Process-focused, supports manufacturing exclusivity |
7. Policies and Patentability Considerations
- Novelty & Inventive Step: The compound and methods must demonstrate novelty over prior art, and non-obviousness considering existing chemical and patent literature.
- Disclosure Requirements: The patent must enable skilled artisans to reproduce claimed compounds and methods.
- Patent Eligibility: The chemical compounds and therapeutic methods are patent-eligible under current US law, provided they do not fall into exceptions.
8. FAQs
Q1. How broad are the claims of US Patent 9,486,412?
A: The claims are broad within the defined chemical structure class, covering a wide range of derivatives fitting the specified formulas, with dependent claims narrowing to specific embodiments.
Q2. What is the strategic importance of this patent for the assignee?
A: It provides exclusive rights to develop, commercialize, and license the core compounds and associated therapeutic methods, creating barriers to entry.
Q3. Can competitors develop similar drugs without infringing?
A: Competitors must design around the claims by altering chemical structures significantly or developing different therapeutic approaches.
Q4. How does this patent relate to patent landscapes in similar drug classes?
A: It complements existing patents by covering novel structures and uses, potentially overlapping or blocking competitors' claims.
Q5. What are potential patent challenges that could arise?
A: Challenges may cite prior art to question novelty or obviousness. Patent validity may also be contested based on claim clarity or inventiveness.
9. Key Takeaways
- Scope & Claims: US 9,486,412 extensively covers the core chemical compounds, their synthesis methods, and therapeutic uses, providing robust exclusivity.
- Patent Landscape Position: It is a pioneering patent within its chemical and therapeutic space, likely to serve as a foundation for future filings.
- Strategic Value: Protects the innovator’s interests for nearly two decades, deterring competitors and facilitating licensing or partnerships.
- Potential Risks: Invalidity risks exist if prior art emerges or if claims are deemed overly broad or indefensible.
- Competitive Dynamics: Companies should analyze related patents for freedom-to-operate and R&D strategies.
References
[1] United States Patent and Trademark Office (USPTO). Patent 9,486,412. Available at: [USPTO Patent Full-Text and Image Database].
[2] Patent landscape reports from [industry-specific patent analytics providers], dated 2022–2023.
[3] Relevant prior art references cited during prosecution (if available).
[4] Comparative patent filings in the chemical and pharmaceutical patent landscape (e.g., Espacenet, WIPO PATENTSCOPE).
Disclaimer: This analysis is for informational purposes and should be supplemented by legal counsel for patent enforcement or prosecution strategies.
